LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Next-Generation Hemoglobin Analyzer Uniquely Ensures Bi-Directional Data Management Future Proofing

By LabMedica International staff writers
Posted on 04 May 2015
Print article
Image: The new point-of-care Hemo Control delivers laboratory-accurate hemoglobin and hematocrit results in one simple test and uniquely offers flexible and enhanced data management with bi-directional interface (Photo courtesy of EKF Diagnostics).
Image: The new point-of-care Hemo Control delivers laboratory-accurate hemoglobin and hematocrit results in one simple test and uniquely offers flexible and enhanced data management with bi-directional interface (Photo courtesy of EKF Diagnostics).
A new point-of-care (POC) diagnostics analyzer delivers quantitative laboratory-accurate hemoglobin and hematocrit results in one simple test and uniquely enables upgrade with data management functionality as required, giving broad flexibility over future connectivity options via its bi-directional interface.

The new robust, portable Hemo Control from EKF Diagnostics (Cardiff, UK) provides accuracy and reliability of results (imprecision of <2%) from 25 seconds for blood banks, hospitals, and clinics. It can easily communicate with in-house systems: using the new LIS2-A2 communication standard, this bi-directional interface allows the analyzer to connect directly to third party software and enable simple integration with LIS (Laboratory Information System) middleware. (LIS2-A2 succeeds the ASTM communication standard commonly used for small to mid-size analyzers and is easier to integrate than POCT-1A.)

This cost-effective basic device stores up to 4,000 patient results and offers enhanced on-board Data Management (DM) functions following upgrade with the DM “add pack” if required at a later date. In addition to enabling lists to be sent directly from the LIS to Hemo Control, DM upgrade also offers barcode identification of patients, operators, cuvette LOT and control materials, as well as quality control with lock-out functions and ability to add comments to results. Hemo Control requires no docking station when handling on-board data management as it uses simple cable connections (e.g. RS-232 to USB or LAN), or integrated Bluetooth technology available with Hemo Control Manager—the top-of-the-range device available with preinstalled DM functions.

“Our new Hemo Control with flexible DM upgrade and bi-directional connectivity is ideal for customers who wish to keep their connectivity options open. This may be because they are planning on future connection of POC devices to the LIS but have yet to decide, or they may need to split costs for budgetary reasons by upgrading at a later date,” said Katja Lemburg, global product manager for hematology.

This compact analyzer is user friendly with step-by-step on-screen instructions, needs no calibration or maintenance, and requires minimal user training. Furthermore, Hemo Control uses NXT shape microcuvette technology, which enables improved finger stick sample collection by virtually eliminating appearance of air bubbles.

Related Links:

EKF Diagnostics
Hemo Control with “Add Pack” options



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more